| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311780 | Urology | 2005 | 5 Pages |
Abstract
None of the treatments investigated had a significant influence on the serum hormonal levels in long-time survivors of testicular cancer. Patients undergoing chemotherapy have no greater risk of developing a hormonal disorder than those following a surveillance strategy, and therapy for testicular cancer is not a risk factor for erectile dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jakob Lackner, Georg Schatzl, Anke Koller, Peter Mazal, Thomas Waldhoer, Michael Marberger, Christian Kratzik,